CAPTRUST Financial Advisors’s Definium Therapeutics DFTX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$571K	Buy	+12,148	New	+$300K	﹤0.01%	2079
2022 Q3	–	Sell	-837	Closed	-$8K	–	3260
2022 Q2	$8K	Buy	837 +585	+232%	+$7.4K	﹤0.01%	3871
2022 Q1	$4K	Sell	252 -67	-21%	-$1.16K	﹤0.01%	4257
2021 Q4	$7K	Buy	319 +49	+18%	+$1.56K	﹤0.01%	3909
2021 Q3	$9K	Buy	270 +1	+0.4%	+$43	﹤0.01%	3675
2021 Q2	$14K	Buy	+269	New	+$14.1K	﹤0.01%	3347

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

CAPTRUST Financial Advisors's DFTX Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 12,148 shares worth $571K. The stake represents ﹤0.01% of the portfolio and ranks #2079 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in DFTX as recently as Q2 2022.

CAPTRUST Financial Advisors first reported a position in DFTX in Q2 2021 and has held it in 6 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

CAPTRUST Financial Advisors held 12,148 shares of Definium Therapeutics worth $571K as of Q2 2026.
Definium Therapeutics was a new CAPTRUST Financial Advisors position in Q2 2026.
Definium Therapeutics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2079 holding.
CAPTRUST Financial Advisors first reported a position in Definium Therapeutics in Q2 2021 and has held it in 6 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.